News

CMM publish data on sex-specific differences in cerebrovascular function and SAH-induced injury
QP Germany adds machine-learning and AI to Qanatpharma’s pipeline
QP Completes Phase 1 Clinical Trial in Healthy Volunteers
Our New Look
A bit about QP

Research at QP is made possible through a dynamic network of private investors, academic collaborators, and support from regulatory bodies in the public sector.

Contact Us
Menu
AboutPlatformLYRIC TrialTeamNews
© Qanatpharma 2024. ALL RIGHTS RESERVED.
ImprintPrivacy Policy